Your browser doesn't support javascript.
loading
Nonalcoholic Fatty Liver Disease and Weight Loss / 中国医学科学院学报
Article em Zh | WPRIM | ID: wpr-690289
Biblioteca responsável: WPRO
ABSTRACT
Nonalcoholic fatty liver disease(NAFLD)refers to hepatic steatosis without other known causes such as alcohol abuse or hepatic virus infection. NAFLD has become a chronic disease worldwide,and its prevalence is constantly growing. Hepatic insulin resistance caused by obesity results in the deposition of triglycerides in the liver,promoting the occurrence and development of NAFLD. Weight loss is the only safe and effective method for NAFLD. Lifestyle intervention plays a cornerstone role in treating NAFLD;however,most patients can not achieve and maintain the ideal body weight by lifestyle intervention alone. Glucagon-like peptide-1 receptor agonist and metabolic surgery are promising treatments for NAFLD.
Texto completo: 1 Base de dados: WPRIM Aspecto: Patient_preference Idioma: Zh Revista: Acta Academiae Medicinae Sinicae Ano de publicação: 2018 Tipo de documento: Article
Texto completo: 1 Base de dados: WPRIM Aspecto: Patient_preference Idioma: Zh Revista: Acta Academiae Medicinae Sinicae Ano de publicação: 2018 Tipo de documento: Article